Lupa Kata Sandi? Klik di Sini

atau Masuk melalui

Belum Memiliki Akun Daftar di Sini


atau Daftar melalui

Sudah Memiliki Akun Masuk di Sini

Konfirmasi Email

Kami telah mengirimkan link aktivasi melalui email ke rudihamdani@gmail.com.

Klik link aktivasi dan dapatkan akses membaca 2 artikel gratis non Laput di koran dan Majalah Tempo

Jika Anda tidak menerima email,
Kirimkan Lagi Sekarang

BPOM Obtains Sinovac Vaccine Test Results from Brazil, Turkey

8 January 2021 15:15 WIB

TEMPO.CO, JakartaHead of the Covid-19 mitigation and national economic recovery committee (PC-PEN Committee) Airlangga Hartarto assures that the Food and Drugs Monitoring Agency (BPOM) has obtained the test reports of the Sinovac vaccine conducted in Brazil and Turkey. 

“The emergency use authorization has been issued in Turkey and we have already received the study report from Brazil,” said Airlangga on Friday, January 8. The minister claims that the BPOM will soon issue its own EUA.

The BPOM will reportedly announce the authorization in a media briefing today. 

Turkey previously reported that the vaccine efficacy rate was 91.25 percent for the CoronaVac after their third trial was completed. They claimed that it can potentially improve following an evaluation from the Turkish scientific committee. 

Meanwhile, Brazil released a report on the experimental vaccine developed by Sinovac Biotech that recorded 78 percent efficacy against Covid-19. 

Read: Sinovac Coronavirus Vaccine 78% Effective in Brazil Trial

BISNIS



Indonesian Govt Reports 100% Recovery of Mpox Cases

3 hari lalu

Indonesian Govt Reports 100% Recovery of Mpox Cases

Minister Budi considered the Mpox outbreak as less severe compared to the COVID-19 outbreak.


Five Key Facts About Mpox Vaccine in Indonesia

5 hari lalu

Five Key Facts About Mpox Vaccine in Indonesia

As Mpox cases continue to rise in Indonesia, the government through the Ministry of Health has initiated a preventive vaccination program.


Indonesia to Share 5,000 Mpox Vaccines with African Countries

5 hari lalu

Indonesia to Share 5,000 Mpox Vaccines with African Countries

Indonesia's plan to share 5,000 monkeypox or Mpox vaccines with African countries is a form of diplomacy.


Groups Prioritized to Receive Mpox Vaccine in Indonesia

5 hari lalu

Groups Prioritized to Receive Mpox Vaccine in Indonesia

Indonesia's Health Ministry said the Mpox vaccine will only be given to high-risk groups, in line with World Health Organization (WHO) recommendations


BPOM: 7,600 Mpox Vaccines Enter Indonesia in Three Stages

11 hari lalu

BPOM: 7,600 Mpox Vaccines Enter Indonesia in Three Stages

The Food and Drug Monitoring Agency (BPOM) says that the Indonesian government brought in monkeypox or mpox vaccines in three stages.


India Develops Mpox Vaccine as Outbreak Declared

17 hari lalu

India Develops Mpox Vaccine as Outbreak Declared

India's leading vaccine maker, the Serum Institute of India (SII), is developing a vaccine for Mpox or monkeypox.


Could Mpox Become Established in the Indo-Pacific?

18 hari lalu

Could Mpox Become Established in the Indo-Pacific?

While the Indo-Pacific has been one of the regions least affected by mpox in the past, that could change if the virus spreads unchecked.


Mpox Is Not the New COVID, Says WHO Official

19 hari lalu

Mpox Is Not the New COVID, Says WHO Official

A World Health Organization official stresses that mpox is not the new COVID.


Indonesian Health Ministry Rolls Out Efforts to Prevent Mpox; Over 4,000 Doses of Vaccines Prepared

19 hari lalu

Indonesian Health Ministry Rolls Out Efforts to Prevent Mpox; Over 4,000 Doses of Vaccines Prepared

Indonesian Ministry of Health says that they are now in the process of preparing 4,450 doses of vaccine to prevent mpox.


Palace on Jokowi's Cabinet Reshuffle: 'Necessary to Support Government Transition'

21 hari lalu

Palace on Jokowi's Cabinet Reshuffle: 'Necessary to Support Government Transition'

The State Palace has provided the reasons behind President Joko Widodo or Jokowi's decision to reshuffle the cabinet this morning, August 19, 2024.